Ann Arbor Stage IV Grade 3 Follicular Lymphoma Active Not Recruiting Phase 2 Trials for Bendamustine (DB06769)

IndicationStatusPhase
DBCOND0093323 (Ann Arbor Stage IV Grade 3 Follicular Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01286272Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin LymphomaTreatment